Thursday, November 26, 2015 1:29:41 PM
The history of the drug (eventually being purified to MST-188) goes back decades. Due to a number of ancient issues relative to insufficient funding and insufficient data gathering practices, it could have all fallen off the proverbial map.
One man had the vision and willingness; with the applications of prior bio-science education and employment experiences, he would challenge those past odds and circumstances, to resurrect a project that was shown an impossible execution under prior attempts. One man, and one other staff member , were it, right? The past executives, scientists and any supporting staff, gone. In most circles thats called a single handed save, any thing like a Hail Mary pass? Well maybe. Anyway I am so grateful thAt he brought it to the team of 30 single focused. today.
Brian Culley has taken this from a company of two to 30 people over the years. The diagram here has been to take some prior information and a one prior drug, through a full series of trials, to full FDA approval. Fortunately the FDA appeared to desire this drug, and so awarded the EPIC trials (three phases) orphan and fast track status. Fast refers to FAST according to FDA. It takes a drug MANY years to work through the 3 phase trial and approval process. The FDA sanctioned that the validated/significant findings from prior explorations with this same drug could be used in the EPIC studies so that time would not be wasted on re dos, from what I understand. They made a few well documented recommendations to improve the studies chances and these have been well addressed.IMO. So much to bre grateful for. Best to all> All stated is IMO. DO your DD.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM